Elad Zvi

Dr. Elad Zvi

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 September 2020 in American Journal of Neuroradiology
Verified
Journal Article
Closed access
PDF file
EZE. Zvi
E. Zvi
ASAsaf Shemer
Asaf Shemer
STShlomi Toussia-Cohen
Shlomi Toussia-Cohen
EZElad Zvi
Elad Zvi
YBY. Bashan
Y. Bashan
EKEldad Katorza
Eldad Katorza
BACKGROUND AND PURPOSE: Very few studies have investigated long-term neurodevelopment of children exposed to MR imaging antenatally. Thus, the purpose of our study was to evaluate long-term neurodevelopmental outcomes of children exposed to MR imaging during pregnancy. MATERIALS AND METHODS: We conducted a historical prospective cohort study in a single tertiary medical center. Women exposed to 1.5T noncontrast MR imaging for maternal or fetal indications were matched to unexposed controls. Long-term neurodevelopmental outcomes were evaluated of their children, 2.5 to 6 years of age, according to the Vineland-II Adaptive Behavior Scale. The Vineland-II Adaptive Behavior Scale assesses communication, daily living skills, socialization, and motor skills. A composite score summarizes these 4 domains. RESULTS: A total of 131 exposed women matched our inclusion criteria and were included in the study group, and 771 unexposed women, in the control group. No difference was identified in the Vineland-II Adaptive Behavior Scale composite score between the children of the study and control groups (mean, 110.79 versus 108.18; P = .098). Differences were also not observed between the children of the 2 groups in 3 of the 4 questionnaire domains: communication (108.84 versus 109.10; P = .888), daily living skills (109.51 versus 108.28; P = .437), and motor skills (105.09 versus 104.42; P = .642). However, the socialization score was favorable for the study group (112.98 versus 106.47; P < .001). CONCLUSIONS: Exposure to 1.5T noncontrast MR imaging during pregnancy had no harmful effects on long-term neurodevelopmental outcomes. This study contributes to understanding the safety of MR imaging during pregnancy.

22 January 2025 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
DKDaniel Josef Kedar
Daniel Josef Kedar
EZElad Zvi
Elad Zvi
OHOriana Haran
Oriana Haran
LSLior Sherker
Lior Sherker
MSMichael Sernitski
Michael Sernitski
YBYoav Barnea
Yoav Barnea
Background/Objectives: Breast cancer-related lymphedema (BCRL) is a chronic complication of breast cancer treatment, leading to physical and psychological morbidity. While widely studied globally, the prevalence and risk factors for BCRL in Israeli patients remain unexplored. This study’s objectives were to determine the prevalence of BCRL in Israeli women treated for breast cancer, validate the Hebrew-translated Norman Questionnaire (NQ) for BCRL screening, and identify risk factors associated with the condition. Methods: A single-center study was conducted at Tel Aviv Sourasky Medical Center, including 181 patients who underwent unilateral axillary lymph node interventions between 2015 and 2018. Participants completed the Hebrew-translated NQ, which was validated through clinical evaluation and circumference-based volume measurements in a subset of 20 patients. Prevalence rates and risk factors were analyzed using multivariate modeling. Results: The prevalence of BCRL was 20%, with rates varying by procedure: 8.9% for sentinel lymph node biopsy, 19.6% for lymph node sampling, and 37.5% for axillary lymph node dissection (ALND). Of the 35 patients with BCRL, only 14% had been previously diagnosed. Risk factors included ALND (OR = 97.31), a higher lymph node excision count (OR = 0.81), and referral to physiotherapy (OR = 133.50). The Hebrew NQ demonstrated strong validity (rs = 0.852; p < 0.001). Conclusions: This is the first study to estimate BCRL prevalence in Israeli women, highlighting underdiagnosis and the need for improved early detection. The Hebrew NQ is a reliable screening tool, enabling timely referral and intervention. Early diagnosis is crucial for optimizing treatment outcomes and improving the quality of life of BCRL patients.

21 March 2026 in JPRAS Open
Verified
Journal Article
Open access
Shiva AkbarzadehShiva Akbarzadeh
Shiva Akbarzadeh
EZElad Zvi
Elad Zvi
CACarlos L. Arellano
Carlos L. Arellano
IBIlia Banakh
Ilia Banakh
MRM. Rahman
M. Rahman
HCHeather Cleland
Heather Cleland
This report describes initial use of a novel bioengineered bilaminar skin substitute to obtain healing in a 6-year-old child with 63% total body surface area (TBSA) full thickness burns. This platelet gel-based Human Skin Equivalent (PG-HSE) autograft differs from other second generation bilaminar biologic skin substitutes, incorporating a platelet - derived hydrogel scaffold. A 5 cm2 skin biopsy was used to manufacture 500 cm2 of bilaminar skin. This was applied to an excised wound bed treated with a biodegradable dermal skin substitute, NovoSorb® Biodegradable Temporizing Matrix (BTM) (PolyNovo Biomaterials Pty Ltd, Port Melbourne, Victoria, Australia). The take rate of the grafted PG-HSE was 95% at 2 weeks post-grafting, with no wound breakdown or requirement for further surgery at the PG-HSE graft sites at 15 months post-grafting. This case demonstrates the efficacy of this bioengineered skin autograft in closing temporized full-thickness burns.

11 May 2026 in European Burn Journal
Verified
Journal Article
Open access
PDF file
EZElad Zvi
Elad Zvi
MNMelissa Neely
Melissa Neely
LHLouise Higgins
Louise Higgins
MGMaja Garcia
Maja Garcia
MPMelinda Pacquola
Melinda Pacquola
CLCheng Hean Lo
Cheng Hean Lo
Background: Burn patients are highly susceptible to hospital-acquired infections (HAIs), and contaminated near-patient surfaces can act as reservoirs for multidrug-resistant organisms (MROs). Ultraviolet-C (UV-C) room disinfection is increasingly used as an adjunct to manual cleaning, but real-world data in adult burns settings remain limited. Methods: We evaluated adjunctive UV-C disinfection in a tertiary adult trauma and burns surgical ward using a two-part observational design. Part A compares MRO-related HAI incidence before UV-C implementation (12 May 2015–11 May 2020; retrospective) with its incidence after implementation (14 July 2020–13 July 2021; prospective). Part B is a matched pre/post environmental sampling study (December 2022–December 2024) of 44 vacant rooms. Paired swabs from a single randomised high-touch surface per room were collected immediately before and after UV-C disinfection and processed by an independent laboratory. Results: Part A included 7589 admissions (6415 before-UV-C; 1174 after-UV-C) with 2728 UV-C cycles delivered after implementation. MRO-related HAI incidence decreased from 18.3 to 10.2 per 1000 bed-days (p < 0.01). In Part B, the proportion of swabs with <10 CFU increased after UV-C disinfection (66% vs. 50%, p = 0.02). Among swabs with non-negligible baseline contamination and excluding increases, the median CFU reduction was 97% (SD 12%; p < 0.001), with no significant differences in reduction across sampled surface types. Conclusion: In an adult burns surgical ward, adjunctive UV-C disinfection was associated with reduced MRO-related HAI incidence and a substantial reduction in environmental bioburden on high-touch surfaces. These real-world findings support UV-C as a feasible adjunct to standard cleaning in high-risk burn services and inform future controlled evaluations.